GLIONOVA

Glionova AB, a development stage biopharmaceutical company, is engaged in the development of therapies for difficult-to-treat cancers. The company develops GLN-1001, an orally bioavailable small molecule that induces selective cell death in glioblastoma cells without causing harm to normal brain tissue.

#SimilarOrganizations #People #Financial #Website #More

GLIONOVA

Social Links:

Facebook

Twitter

Industry:

Biopharma Biotechnology Pharmaceutical

Founded:

2014-01-01

Address:

Stockholm, Stockholms Lan, Sweden

Country:

Sweden

Website Url:

http://www.glionova.com

Total Employee:

Status:

Active

Contact:

+46 70 540 6519

Total Funding:

5.7 M USD

Technology used in webpage:

OpenResty Baidu Analytics DNS.COM

Similar Organizations

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

urovant-sciences-logo

Urovant Sciences

Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.

Current Employees Featured

eugen-steiner_image

Eugen Steiner
Eugen Steiner CEO @ Glionova
CEO

not_available_image

Lars Hammarström
Lars Hammarström Founder, Director, Health and Life Science Division @ Glionova
Founder, Director, Health and Life Science Division
2020-02-01

Founder

not_available_image

Lars Hammarström

Investors List

novo-a-s_image

Official Site Inspections

http://www.glionova.com

Host Informations
Whois Informations

Loading ...